摘要
该研究调查了阿尔茨海默病(AD)与年龄相关的黄斑变性(AMD)的迹象。这些衰老相关疾病主要影响中枢神经系统的不同部分,但实质上类似于异常细胞代谢和氧化应激、神经炎症和微血管异常。而AMD是视网膜疾病,据报道, 阿尔茨海默病不仅影响大脑还视网膜,Aβ细胞、神经退化和血管的变化。关于阿尔茨海默病和AMD研究基于人口众多为疾病的提供了相互矛盾的结果。 本研究调查了AMD一个小的迹象,但非常实验澳大利亚成像生物标志物的特征和生活方式研究衰老的(AIBL)。实验由22例(70.2±9.0岁,年龄13岁男,9女)和101年认知正常(CN)参与者(71.3±6.0岁,40岁男性,61名女性)组成。 与CN组相比, 阿尔茨海默病组有更大比例的参与者与早期AMD(p < 0.0001,优势比为18.67,95%可信区间4.42 - 78.80)。物流模型对早期AMD发现重大阿尔茨海默病进行了诊断(p < 0.0001),在调整了混杂因素(年龄、吸烟、高血压、高、低密度脂蛋白,白内障手术和APOEε4载体状态)。 这项研究的结果的与AMD和阿尔茨海默病的风险增加是一致。虽然这些疾病的病理生理学是不清楚,理解它们之间的特性可以提供进一步的认识,并可能导致加速对其发病机理和治疗这两种疾病研究的发展。
关键词: 老化、诊断、阿尔茨海默氏病、视网膜、眼睛、视力障碍。
Current Alzheimer Research
Title:Alzheimer’s Disease and the Early Signs of Age-Related Macular Degeneration
Volume: 13 Issue: 11
Author(s): Shaun Frost, Robyn Guymer, Khin Zaw Aung, S. Lance Macaulay, Hamid R Sohrabi, Pierrick Bourgeat, Olivier Salvado and Christopher C. Rowe, David Ames, Colin L. Masters, Ralph N. Martins, Yogesan Kanagasingam, the AIBL Research Group
Affiliation:
关键词: 老化、诊断、阿尔茨海默氏病、视网膜、眼睛、视力障碍。
摘要: This study investigated signs of age related macular degeneration (AMD) in Alzheimer’s disease (AD). These age-related diseases primarily affect different parts of the central nervous system but are substantially similar in terms of abnormal extracellular deposits, metabolic and oxidative stress, neuroinflammation and microvascular abnormalities. While AMD is a retinal disease, AD is reported to affect not only the brain but also the retina, with Aβ deposits, neurodegeneration and vascular changes. Large population based studies have provided conflicting results regarding the comorbidity of AD and AMD.
This study investigated signs of AMD in a small but well characterized cohort from the Australian Imaging Biomarkers and Lifestyle study of aging (AIBL). The cohort consisted of 22 AD patients (age 70.2 ± 9.0 yrs, 13 male, 9 female) and 101 cognitively normal (CN) participants (age 71.3 ± 6.0 yrs, 40 male, 61 female).
In comparison with the CN group, the AD group had a greater proportion of participants with early AMD (p < 0.0001, odds ratio 18.67, 95% CI 4.42 – 78.80). A logistic model for early AMD found a significant association with AD diagnosis (p < 0.0001), after adjusting for confounders (age, smoking, hypertension, high and low density lipoproteins, cataract surgery and APOE ε4 carrier status).
The results of this study are consistent with an increased risk of AMD in AD. While the pathophysiology of these diseases are unclear, understanding the shared features between them may provide further knowledge about their pathogenesis and could lead to accelerated development of therapies for both diseases.
Export Options
About this article
Cite this article as:
Shaun Frost, Robyn Guymer, Khin Zaw Aung, S. Lance Macaulay, Hamid R Sohrabi, Pierrick Bourgeat, Olivier Salvado and Christopher C. Rowe, David Ames, Colin L. Masters, Ralph N. Martins, Yogesan Kanagasingam, the AIBL Research Group , Alzheimer’s Disease and the Early Signs of Age-Related Macular Degeneration, Current Alzheimer Research 2016; 13 (11) . https://dx.doi.org/10.2174/1567205013666160603003800
DOI https://dx.doi.org/10.2174/1567205013666160603003800 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain
Current Neuropharmacology The Relationship Between Epilepsy and Depression: An Update
Current Medicinal Chemistry Oestradiol Signalling in the Hippocampus
Current Neuropharmacology Diabetes NEP-Like Endopeptidases and Alzheimers Disease
Current Alzheimer Research Editorial - The As and Ms of Alzheimers Disease
Current Alzheimer Research Identification of Pharmacological Targets in Amyotrophic Lateral Sclerosis Through Genomic Analysis of Deregulated Genes and Pathways
Current Genomics Editorial [Hot Topic: Innate Immune Responses in CNS Neurodegenerative Diseases (Guest Editors: Hans van Noort and Sandra Amor)]
CNS & Neurological Disorders - Drug Targets Editorial: Impact of Racial Differences on Brain Health among the Oldest Old
Current Alzheimer Research Soothing the Inflamed Brain: Effect of Non-Steroidal Anti-Inflammatory Drugs on Alzheimers Disease Pathology
CNS & Neurological Disorders - Drug Targets Mechanisms of HIV-1 Neurotropism
Current HIV Research Tools For Decision-Making In Older Cancer Patients. Role Of The Comprehensive Geriatric Assessment
Anti-Cancer Agents in Medicinal Chemistry A More Accurate Approach to Molecular Genetics Analysis in Vascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Development of Tablet Device App for Parkinson’s Disease Patients’ Continuous Self-Monitoring and Management
Neuroscience and Biomedical Engineering (Discontinued) New Developments of Clinical Trial in Immunotherapy for Alzheimer's Disease
Current Pharmaceutical Biotechnology Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design Gene-environment Interactions in Late Life: Linking Psychosocial Stress with Brain Aging
Current Neuropharmacology Extraction, Structure and Bioactivities of the Polysaccharides from Fructus corni
Recent Patents on Food, Nutrition & Agriculture The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review
Protein & Peptide Letters Metabolic Programming Nowadays (or Perhaps Now and then?)
Current Nutrition & Food Science Exogenous Progesterone: A Potential Therapeutic Candidate in CNS Injury and Neurodegeneration
Current Medicinal Chemistry